NanoViricides Inc. (NNVC)

[KuChing]

Everyone forgets ROI. Return On Investment. I am making the point about the effectiveness by which Nanoviricides Inc. invests the less than 10% of the $40M of public funding it has access to. If that leads to an IND trial, and Tox package for DengueCide, then it will be a fantastic investment. If it merely pays the salaries of those trying to find a viable business plan then, it will bust the company. The Docs know that. Most of the market knows that. That’s why the Docs have waited to pull the trigger. They have pulled the trigger. They are going for it.

Fear based personalities don’t get it. Fact based personalities get that NNVC is on the goal line ready to score and score quickly and often. That is the wild card. That drives the demand to have a piece of this company. Know one can stop it.

Anti-virals have a short timeline to trial outcome. This business model confounds the chartists, and the prognosticators because everyone knows in there heart of hearts that it doesn’t get any better than this for the gusher of all pharmaceuticals. Market psychology makes the charts, not the other way around.